Cleared Traditional

K951877 - AUTOMATED ANALYSIS ASSAY FOR BILIRUBIN ...

K951877 is an FDA 510(k) clearance for AUTOMATED ANALYSIS ASSAY FOR BILIRUBIN ..., manufactured by Chimera Research & Chemical, Inc.. The device is a Class 1 Chemistry device with product code KQO cleared through the Traditional 510(k) pathway after a 403-day FDA review.

K951877 · Chimera Research & Chemical, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1996
Decision
403d
Days
Class 1
Risk

K951877 is an FDA 510(k) clearance for the AUTOMATED ANALYSIS ASSAY FOR BILIRUBIN IN URINE. Classified as Automated Urinalysis System (product code KQO), Class I - General Controls.

Submitted by Chimera Research & Chemical, Inc. (Seminole, US). The FDA issued a Cleared decision on May 14, 1996 after a review of 403 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.2900 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Chemistry submissions.

View all Chimera Research & Chemical, Inc. devices

FDA 510(k) Submission Details - K951877

510(k) Number K951877 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 07, 1995
Decision Date May 14, 1996
Days to Decision 403 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
315d slower than avg
Panel avg: 88d · This submission: 403d
Pathway characteristics
Predicate-based equivalence.

KQO Device Classification - Class 1, General Controls

Product Code KQO Automated Urinalysis System
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.2900
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - KQO Automated Urinalysis System

All 24
Devices cleared under the same product code (KQO) and FDA review panel - the closest regulatory comparables to K951877.
CHEMSTRIP 101 URINE ANALYZER
K983510 · Boehringer Mannheim Corp. · Oct 1998
STC DIAGNOSTICS AUTO-LYTE URINARY LEUKOCYTE ESTERASE ASSAY
K954156 · Solarcare Technologies Corp,Inc. · Jul 1996
CLINITEK 50 URINE CHEMISTRY ANALYZER
K960546 · Bayer Corp. · Jun 1996
STC DIAGNOSTICS AUTO-LYTE PH ASSAY
K954158 · Solarcare Technologies Corp,Inc. · Apr 1996
CHEMSTRIP CRITERION URINE ANALYZER
K954024 · Boehringer Mannheim Corp. · Oct 1995
CLINITEK ATLAS AUTOMATED URINE CHEMISTRY ANALYZER
K946183 · Heraeus Kulzer, Inc. · Feb 1995